. Rapamycin reduced anti-Ad IgM production. C57BL/6 mice (n=8) were treated according to the protocol shown in Figure 3A . Mouse serum samples were collected at the end of study and subjected to ELISA for anti-Ad IgM titration. **, P<0.01 by unpaired two-tailed t test. Figure 3 . Intraperitoneal RAPA treatment (5 mg/kg/day) was started on day 7 and continued until the end of the study in both models. Tumors were measured by a caliper trice per week (C) or everyday (D) and the tumor volume was calculated as length× (width) 2 ×0.52.
Animals in the control cohorts were sacrificed when tumor reached the 1.5 cm limit; mice in the RAPA cohorts were sacrificed at arbitrary study end points. Since MycCap cells are sensitive to GCV as a single agent, GCV was added in both the control and RAPA groups in (C). Panel (C) shows tumor volume normalized to corresponding day-5 values (n=3) and panel (D) shows absolute tumor volume (n=8).
